Form 4: Royalty Pharma Director Bonnie L. Bassler Acquires Shares in Lieu of Retainer

Director Bonnie L. Bassler acquired 1,399 Class A Ordinary Shares of Royalty Pharma plc in lieu of a quarterly retainer payment.

Summary

• On June 28, 2024, Bonnie L. Bassler, a director of Royalty Pharma plc, acquired 1,399 Class A Ordinary Shares.
• The shares were issued under the Issuer's 2020 Independent Director Equity Incentive Plan.
• The acquisition was in lieu of a quarterly retainer payment of $37,500.
• The price per share was $26.7998.
• Following the transaction, Ms. Bassler beneficially owns 58,454 Class A Ordinary Shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares is generally a good sign, but the amount is relatively small and part of regular compensation.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The use of equity in lieu of cash preserves the company's cash reserves.

Industry Context

Directors often receive equity as part of their compensation, aligning their interests with those of shareholders. This is a common practice in the pharmaceutical and biotechnology industries.

Related Party Transactions

• The issuance of shares to Bonnie L. Bassler, a director, in lieu of a cash retainer payment is a related party transaction.

Stakeholder Impact

• Shareholders may view the director's share acquisition positively.
• The company benefits from preserving cash by issuing equity.

Key Dates